Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News
zytiga image

Janssen agrees Zytiga deal

October 14, 2013
Sales and Marketing AstraZeneca, Janssen, Zytiga

Janssen has agreed to co-promote its once-daily prostate cancer pill Zytiga with AstraZeneca in Japan for an undisclosed sum. A …

News
alderley image

More companies join AZ’s BioHub

October 3, 2013
Research and Development, Sales and Marketing AstraZeneca, Cambridge, alderley

Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …

News
iphone_4

AZ/Daiichi Sankyo create Japan iPhone app for acid reflux

September 19, 2013
Medical Communications, Sales and Marketing AstraZeneca, Daiichi Sankyo, Japan, Nexium, app, iphone

News
astrazeneca image

AstraZeneca pays Merck for cancer drug

September 11, 2013
Sales and Marketing AstraZeneca, Cancer, Merck, WEE1

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …

News
astrazeneca image

AstraZeneca begins olaparib programme

September 4, 2013
Sales and Marketing AstraZeneca, olaparib, ovarian cancer

AstraZeneca has begun recruitment in its Phase III programme for olaparib, a potential first-in-class oral poly ADP ribose polymerase (PARP) …

News
astrazeneca_alderley

AstraZeneca buys cancer specialist

August 27, 2013
Research and Development, Sales and Marketing Amplimmune, AstraZeneca, Cancer, MedImmune

News

Seroquel loss hits AstraZeneca

August 2, 2013
Sales and Marketing AstraZeneca, Q2, Seroquel, symbicourt

Loss of exclusivity on brands such as the antipsychotic Seroquel IR helped put a $500 million dent in AstraZeneca’s performance …

News
astrazeneca image

AstraZeneca signs $350m kidney deal

August 1, 2013
Sales and Marketing AstraZeneca, CKD, fibrogen, kidney

AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …

News
AstraZeneca image

AstraZeneca staff questioned in China

July 23, 2013
Medical Communications, Sales and Marketing AstraZeneca, China, GSK, bribery

AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …

News
Nexium image

Nexium gets its own promotional YouTube channel

July 17, 2013
Medical Communications AstraZeneca, Nexium, reflux, youtube

AstraZeneca’s once biggest selling drug Nexium has been given its own YouTube channel in the hope of shoring up sales …

News
simon_lowth_az

Simon Lowth exits AstraZeneca

July 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth

AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …

Appointment
AZ Cambridge

AstraZeneca shores up Cambridge move

July 11, 2013
Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development

AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …

News
Cambridge image

AstraZeneca chooses Cambridge for global HQ

June 19, 2013
Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune

AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …

News
Medimmune image

MedImmune signs diabetes deal

June 18, 2013
Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes

AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025